Overview
Eddine Bendiab practices practicing medicine in Montpellier, France.
Their clinical expertise encompasses Guillain-Barre Syndrome, Transient Global Amnesia, and Metabolic Acidosis.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Eddine Bendiab
Is Eddine Bendiab a top-rated expert for Guillain-Barre Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Eddine Bendiab is classified as an Experienced expert for Guillain-Barre Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Eddine Bendiab participate in research or clinical trials?
Yes. Eddine Bendiab has published 8 articles and abstracts on conditions like Guillain-Barre Syndrome. You can view a list of Eddine Bendiab's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Guillain-Barre SyndromeBendiab isExperienced. Learn about Guillain-Barre Syndrome.
- Metabolic AcidosisBendiab isExperienced. Learn about Metabolic Acidosis.
- Transient Global AmnesiaBendiab isExperienced. Learn about Transient Global Amnesia.